We are very honored to be featured again as one of MM+M Top 100 Agencies for 2020. Read the full article where our CEO, Michael Parisi, discusses highlights from the year and Guidemark Health’s direction going forward. ow.ly/J8D450AsP22

Learn how healthcare marketers can navigate challenges and succeed in with podcast advertising. #PartnerContent Guidemark Health, a Lumanity business bit.ly/2OmBQ2c

Our own programmatic in-house expert, Alexander Lindroth, recently wrote a piece in MM+M on engaging podcast enthusiasts. With podcasts continuing to rise in popularity, it’s no surprise that focus has shifted to important topics like healthcare. ow.ly/OekD50AygBU

In a report from IAB & PwC, podcasts to continue to grow as they gain a more prominent position in brand planning. IAB will host its 2020 Podcast Upfront this September as marketers are eager to see the latest in programming & secure premium partnerships. ow.ly/4MG650AAiSf

As national anxiety about #COVID19 threatens to boil over, the country is left with the same daunting questions. Don't miss the opportunity to hear directly from Dr. Fauci & other medical experts during a free Town Hall through Healthline! Check it out: bit.ly/3kDA5MW

Check out Becky’s story, the latest addition to our 29 stories campaign! guidemarkhealth.com/29-stories/#be…

Go beyond the pink. This #BCAM learn about important issues impacting the community now. In our latest blog we spoke with Andrea Ottaiano, survivor and advocate, to discuss the new FDA-recommended black box warning to be included with breast implants: bit.ly/3kNtQGp

Must watch: Hear Dr. Fauci’s state of the union on all things COVID-19, from vaccination to treatment to post–COVID-19 syndrome, including tips on engaging the anti-vaxxer community. bit.ly/2JXGlkS

Week one of celebrating #BlackHistoryMonth we pay tribute to the history makers—both famous and those less known heroes who paved the way for countless others in the pursuit of equality. Read about Claudette Colvin’s courageous act when she was just 15: bit.ly/39McDtH

We’ll be ringing Nasdaq closing bell tomorrow to celebrate #Kidney Awareness Month and our continued focus on developing new therapeutics for relapsed or refractory renal cell carcinoma #RCC $AVEO #RewriteTomorrow

Our partner AVEO Oncology will ring the #NASDAQ closing bell today in honor of National #Kidney #Cancer Awareness Month. Check out this article from Healthline to learn the risk factors and how you can get involved. bit.ly/2NXH1sR #RCC

Training for MSLs in a post-pandemic world will look a bit different. Listen as Guidemark Health’s Michael Parisi and Marissa Poli discuss the implications of reentry and the importance of career on ramp training on the MSL Talk podcast -> bit.ly/2P98V64

We are thrilled to launch our WeConvEEn - Energizing Engagement platform. The offering enables our clients to seamlessly engage with their diverse customer segments–HCPs, health care organizations, and patient communities. Request your free tour here: weconveen.com

Guidemark Health is thrilled to be included as an MM+M Top 100 Agency this year. Check out our #MMMAgency100 profile to see the movie poster that represents the agency’s personality: bit.ly/35YtOWp

We are excited to announce Arsenal Growth has acquired Guidemark Health, a Lumanity business to complement Cello Health Global and BresMed offerings in demonstrating value and optimizing access to new therapies. Full press release here: bit.ly/31pC9mP #pharmaceutical #biotech #strategy

We are committed to driving awareness of rare diseases. We are proud of the work we do to support rare disease communities. And we are honored to be trusted with the responsibility. We invite you to see how here: guidemarkhealth.com/news/ #RDD2022 #RareDiseaseDay2022

We are excited to be a Lumanity business and we’ll be celebrating all week as we introduce our new health-focused brand to the world. Read the full release here: lumanity.com/introducing-lu… #wearelumanity

March is #KidneyCancerAwarenessMonth. Kidney cancer is among the top 10 most common cancers, afflicting almost 79,000 people in the U.S. each year. Know the symptoms and risk factors: kidneycancer.org/fast-facts/

Lumanity has acquired Endpoint Outcomes, a company specializing in harnessing the voice of patients to document the impact of treatments on health-related quality of life. This strengthens Lumanity's comprehensive & global #HEOR services. bit.ly/3tCca6R #outcomesresearch